Patents by Inventor Javier Szwarcberg

Javier Szwarcberg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of Administering Pirfenidone Therapy
    Publication number: 20130030024
    Abstract: The present invention relates to methods involving avoiding adverse drug interactions with fluvoxamine and pirfenidone or other moderate to strong inhibitors of CYP enzymes.
    Type: Application
    Filed: December 3, 2010
    Publication date: January 31, 2013
    Applicant: INTERMUNE ,INC.
    Inventors: Williamson Z. Bradford, Javier Szwarcberg
  • Methods of administering pirfenidone therapy
    Patent number: 8318780
    Abstract: The present invention relates to methods involving avoiding adverse drug interactions with fluvoxamine and pirfenidone or other moderate to strong inhibitors of CYP enzymes.
    Type: Grant
    Filed: September 2, 2011
    Date of Patent: November 27, 2012
    Assignee: Intermune, Inc.
    Inventors: Williamson Ziegler Bradford, Javier Szwarcberg
  • Pirfenidone Therapy and Inducers of Cytochrome P450
    Publication number: 20120088801
    Abstract: The present invention relates to methods involving avoiding adverse drug interactions with pirfenidone and CYP inducers, such as smoking.
    Type: Application
    Filed: December 15, 2011
    Publication date: April 12, 2012
    Applicant: INTERMUNE, INC.
    Inventors: Williamson Z. Bradford, Javier Szwarcberg
  • PIRFENIDONE TREATMENT FOR PATIENTS WITH ATYPICAL LIVER FUNCTION
    Publication number: 20120077850
    Abstract: Methods are provided for administering pirfenidone to a patient that has exhibited abnormal biomarkers of liver function in response to pirfenidone administration. The methods include administering to a patient pirfenidone at doses lower than the full target dosage for a time period, followed by administering to the patient pirfenidone at the full target dosage. The methods also include administering pirfenidone at the full target dose with no reduction and administering permanently reduced doses of pirfenidone.
    Type: Application
    Filed: December 6, 2011
    Publication date: March 29, 2012
    Applicant: INTERMUNE, INC.
    Inventors: Williamson Z. Bradford, Javier Szwarcberg
  • Methods of Administering Pirfenidone Therapy
    Publication number: 20120015985
    Abstract: The present invention relates to methods involving avoiding adverse drug interactions with fluvoxamine and pirfenidone or other moderate to strong inhibitors of CYP enzymes.
    Type: Application
    Filed: September 26, 2011
    Publication date: January 19, 2012
    Applicant: INTERMUNE, INC.
    Inventors: Williamson Z. Bradford, Javier Szwarcberg
  • Methods of Administering Pirfenidone Therapy
    Publication number: 20110319453
    Abstract: The present invention relates to methods involving avoiding adverse drug interactions with fluvoxamine and pirfenidone or other moderate to strong inhibitors of CYP enzymes.
    Type: Application
    Filed: September 2, 2011
    Publication date: December 29, 2011
    Applicant: INTERMUNE, INC.
    Inventors: Williamson Z. Bradford, Javier Szwarcberg
  • Pirfenidone therapy and inducers of cytochrome P450
    Patent number: 8084475
    Abstract: The present invention relates to methods involving avoiding adverse drug interactions with pirfenidone and CYP inducers, such as smoking.
    Type: Grant
    Filed: January 8, 2010
    Date of Patent: December 27, 2011
    Assignee: Intermune, Inc.
    Inventors: Williamson Ziegler Bradford, Javier Szwarcberg
  • Pirfenidone Treatment for Patients with Atypical Liver Function
    Publication number: 20110263656
    Abstract: Methods are provided for administering pirfenidone to a patient that has exhibited abnormal biomarkers of liver function in response to pirfenidone administration. The methods include administering to a patient pirfenidone at doses lower than the full target dosage for a time period, followed by administering to the patient pirfenidone at the full target dosage. The methods also include administering pirfenidone at the full target dose with no reduction and administering permanently reduced doses of pirfenidone.
    Type: Application
    Filed: November 9, 2009
    Publication date: October 27, 2011
    Applicant: INTERMUNE, INC.
    Inventors: Williamson Z. Bradford, Javier Szwarcberg
  • Methods of administering pirfenidone therapy
    Patent number: 8013002
    Abstract: The present invention relates to methods involving avoiding adverse drug interactions with fluvoxamine and pirfenidone or other moderate to strong inhibitors of CYP enzymes.
    Type: Grant
    Filed: March 16, 2011
    Date of Patent: September 6, 2011
    Assignee: Intermune, Inc.
    Inventors: Williamson Ziegler Bradford, Javier Szwarcberg
  • PIRFENIDONE THERAPY AND INDUCERS OF CYTOCHROME P450
    Publication number: 20110172277
    Abstract: The present invention relates to methods involving avoiding adverse drug interactions with pirfenidone and CYP inducers, such as smoking.
    Type: Application
    Filed: January 8, 2010
    Publication date: July 14, 2011
    Applicant: INTERMUNE, INC.
    Inventors: Williamson Z. Bradford, Javier Szwarcberg
  • METHODS OF ADMINISTERING PIRFENIDONE THERAPY
    Publication number: 20110166186
    Abstract: The present invention relates to methods involving avoiding adverse drug interactions with fluvoxamine and pirfenidone or other moderate to strong inhibitors of CYP enzymes.
    Type: Application
    Filed: March 16, 2011
    Publication date: July 7, 2011
    Applicant: INTERMUNE, INC.
    Inventors: Williamson Z. Bradford, Javier Szwarcberg
  • Methods of administering pirfenidone therapy
    Patent number: 7910610
    Abstract: The present invention relates to methods involving avoiding adverse drug interactions with fluvoxamine and pirfenidone or other moderate to strong inhibitors of CYP enzymes.
    Type: Grant
    Filed: October 8, 2010
    Date of Patent: March 22, 2011
    Assignee: Intermune, Inc.
    Inventors: Williamson Ziegler Bradford, Javier Szwarcberg
  • Methods of administering pirfenidone therapy
    Patent number: 7816383
    Abstract: The present invention relates to methods involving avoiding adverse drug interactions with fluvoxamine and pirfenidone or other moderate to strong inhibitors of CYP enzymes.
    Type: Grant
    Filed: January 8, 2010
    Date of Patent: October 19, 2010
    Assignee: Intermune, Inc.
    Inventors: Williamson Ziegler Bradford, Javier Szwarcberg
  • Pirfenidone treatment for patients with atypical liver function
    Patent number: 7635707
    Abstract: Methods are provided for administering pirfenidone to a patient that has exhibited abnormal biomarkers of liver function in response to pirfenidone administration. The methods include administering to a patient pirfenidone at doses lower than the full target dosage for a time period, followed by administering to the patient pirfenidone at the full target dosage. The methods also include administering pirfenidone at the full target dose with no reduction and administering permanently reduced doses of pirfenidone.
    Type: Grant
    Filed: September 3, 2009
    Date of Patent: December 22, 2009
    Assignee: Intermune, Inc.
    Inventors: Williamson Ziegler Bradford, Javier Szwarcberg
  • Modifying pirfenidone treatment for patients with atypical liver function
    Patent number: 7566729
    Abstract: Methods are provided for administering pirfenidone to a patient that has exhibited abnormal biomarkers of liver function in response to pirfenidone administration. The methods include administering to a patient pirfenidone at doses lower than the full target dosage for a time period, followed by administering to the patient pirfenidone at the full target dosage.
    Type: Grant
    Filed: April 22, 2009
    Date of Patent: July 28, 2009
    Assignee: Intermune, Inc.
    Inventors: Williamson Ziegler Bradford, Javier Szwarcberg